SOST and chronic kidney disease: This increase is likely the result of an increased production of sclerostin, since a recent clinical study in 120 patients with CKD stage 1–5 showed an increased rather than a decreased absolute and fractional urinary excretion of sclerostin with declining kidney function [10].